Full Portfolio
Unified search across all four categories — formulation licenses / APIs / intermediates / excipients. This is the full-catalog view; use the entries below to browse by category.
Browse by Type
Click a type to filter the catalogue below. Use the category tabs above for totals across the API, excipient and qualified-intermediate catalogues; this table shows the main catalogue only.Licensing pipelinePublic
JAK1 (oral)
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB363)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
JAK1 (oral)
— · —
- Therapy Area
- Dermatology
- Current Status
- Candidate licensing (UB362)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
JAK1 (oral)
— · —
- Therapy Area
- Dermatology
- Current Status
- Candidate licensing (UB361)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
P2Y12R
— · —
- Therapy Area
- Cardiovascular
- Current Status
- Candidate licensing (UB360)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- United States
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
UB356
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB356)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
UB355
— · —
- Therapy Area
- Others > Respiratory
- Current Status
- Candidate licensing (UB355)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
UB354
— · —
- Therapy Area
- Infectious Diseases
- Current Status
- Candidate licensing (UB354)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
SYK inhibitor
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB353)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
αActRII; αMyostatin
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB352)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- South Korea
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1; GLP-2
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB351)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- South Korea
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1; GLP-2
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB350)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- South Korea
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
ASK-1
— · —
- Therapy Area
- Gastroenterology & Hepatology
- Current Status
- Candidate licensing (UB349)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
Surface Antigen HBsAg
— · —
- Therapy Area
- Infectious Diseases
- Current Status
- Candidate licensing (UB348)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
Core Protein CpAM
— · —
- Therapy Area
- Infectious Diseases
- Current Status
- Candidate licensing (UB347)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
IL-6R; TNF-α
— · —
- Therapy Area
- Ophthalmology
- Current Status
- Candidate licensing (UB345)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
IL-6R; IL-23p19
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB344)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
TL1A; IL-6R
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB343)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
TL1A; TNF-α
— · —
- Therapy Area
- Rheumatology
- Current Status
- Candidate licensing (UB342)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
TL1A; IL-23p19
— · —
- Therapy Area
- Dermatology
- Current Status
- Candidate licensing (UB341)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
TL1A
— · —
- Therapy Area
- Gastroenterology & Hepatology
- Current Status
- Candidate licensing (UB340)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
IL-2R
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB339)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
IL-1R1
— · —
- Therapy Area
- Rheumatology
- Current Status
- Candidate licensing (UB338)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
CD80; CD86
— · —
- Therapy Area
- Rheumatology
- Current Status
- Candidate licensing (UB337)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
IL-6R
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB336)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
IL-6R
— · —
- Therapy Area
- Rheumatology
- Current Status
- Candidate licensing (UB335)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
(BsAb)
— · —
- Therapy Area
- Nephrology & Urology
- Current Status
- Candidate licensing (UB333)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
(BsAb)
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB332)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
HPK-1
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB324)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
FGFR2b; DNA Topoisomerase I
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB323)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
MUC17; DNA Topoisomerase I
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB322)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
CDH17; DNA Topoisomerase I
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB321)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
ROR1; DNA Topoisomerase I
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB320)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
ROR1; DNA Topoisomerase I
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB319)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
ROR1; DNA Topoisomerase I
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB318)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1; GIP
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB317)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1; GIP
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB316)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1; GIP
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB315)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1 (oral)
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB313)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1 (oral)
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB312)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
JAK1; JAK2
— · —
- Therapy Area
- Immunology & Inflammation
- Current Status
- Candidate licensing (UB310)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
JAK1; JAK2
— · —
- Therapy Area
- Dermatology
- Current Status
- Candidate licensing (UB309)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
VEGF-A
— · —
- Therapy Area
- Ophthalmology
- Current Status
- Candidate licensing (UB302)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
Insulin receptor
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB298)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- Unknown
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
Tumor neuantigens
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB285)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
AChE
— · —
- Therapy Area
- Neurology
- Current Status
- Candidate licensing (UB284)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
CD38
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB267)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
CD38
— · —
- Therapy Area
- Oncology
- Current Status
- Candidate licensing (UB266)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.
Licensing pipelinePublic
GLP-1 R
— · —
- Therapy Area
- Metabolic & Endocrinology
- Current Status
- Candidate licensing (UB263)· Preclinical
- Registration Pathway
- Licensing / co-development (by target & stage)
- Price Range
- On request
- Registrable Markets
- China
Supplier：Unibest Industrial Co., Ltd.